Original Research

The Wisconsin Upper Respiratory Symptom Survey (WURSS)

Author and Disclosure Information

A New Research Instrument for Assessing the Common Cold


 

References

ABSTRACT

OBJECTIVE: To develop a sensitive, reliable, responsive, and easy-to-use instrument for assessing the severity and functional impact of the common cold.

STUDY DESIGN: We created an illness-specific health-related quality-of-life outcomes instrument using previous scales, expert opinion, and common knowledge. This original questionnaire was used in a 1999 randomized trial of echinacea for the common cold. In 2000 we employed cognitive interview and focus group qualitative methods to further develop the instrument. Semistructured interviews used open-ended questions to elicit symptoms, terminology, and perceived functional impact. Responses were used to improve the instrument.

POPULATION: The randomized trial watched 142 University of Wisconsin students for a total of 953 days of illness. The subsequent qualitative instrument development project recruited 74 adults with self-diagnosed colds for 56 in-person interviews and 3 focus groups.

OUTCOMES MEASURED: We measured specific symptoms, symptom clusters (dimensions), functional impact, and global severity.

RESULTS: The original questionnaire included 20 questions: a global severity indicator, 15 symptom-severity items using 9-point severity scales, and 4 yes/no functional assessments. Data from the trial provided evidence of 4 underlying dimensions: nasal, throat, cough, and fever and aches, with reliability coefficients of 0.663, 0.668, 0.794, and 0.753, respectively. Qualitative assessments from the interviews and focus groups led us to expand from 15 to 32 symptom-specific items and from 4 to 10 functional impairment items. The original 9-point severity scale was revised to 7 points. Two global severity questions bring the item count to 44. The instrument fits comfortably on the front and back of a single sheet of paper and takes 5 to 10 minutes to complete.

CONCLUSIONS: The Wisconsin Upper Respiratory Symptom Survey (WURSS) is now ready for formal validity testing or practical use in common cold research.

The common cold, usually caused by viral infection of the upper respiratory tract, is a very prevalent illness. On average, US adults suffer from 1 to 4 episodes per year.1-3 This high incidence, along with significant symptomatic and functional impairment, combine to make this syndrome an important health problem. Hundreds of trials have attempted to demonstrate effective treatments.4,5 Unfortunately, few efforts have been made to develop and validate instruments to measure the symptomatic and functional impact of the common cold.

The term “upper respiratory infection” (URI) is a nosologic category constructed by physicians and other health professionals to reflect an upper airway, mucus-producing, inflammatory reaction to infection, usually viral. It is a disease category. The terms rhinitis, rhinosinusitis, pharyngitis, and bronchitis are often used to indicate the anatomic area most affected. The term “common cold” is an illness term constructed and used by the general populace. This distinction between professional (disease) and popular (illness) conceptions6 provides the reasoning for participant-based, patient-oriented qualitative development of measurement tools. While many medical professionals may choose to measure URI disease by physical examination, viral culture, or laboratory analysis of blood or nasal discharge, we believe that most people are more interested in how they can reduce the severity and duration of their symptoms and the functional impairments that result from their illness.

George Gee Jackson and colleagues7 began experimental work in the 1950s, observing and recording the cold symptoms produced by challenging more than 1,000 volunteers with filtered nasal secretions obtained from cold-sufferers. Eight symptoms–sneezing, headache, malaise, chilliness, nasal discharge, nasal obstruction, sore throat, and cough–were selected for evaluation and graded as absent (0), mild (1), moderate (2), or severe (3) every day for 6 days after inoculation. A score of 14 or higher was chosen as the cutoff value that best distinguished infected from noninfected participants. Thus, the original Jackson scale was apparently designed to discriminate between those with and without demonstrable viral infection, and not as a measure of severity. The tables and graphics in Jackson’s seminal works point toward reasonable internal consistency and discriminate validity.7-9 However, other important measurement properties, such as precision, reliability, responsiveness, and stability, were not reported. Despite these limitations, Jackson’s scale has been used for decades by most of the major common cold research groups.10-15

Using various modifications of the Jackson scale, researchers of the cold have characterized the frequency and severity of the 8 symptoms noted above in both natural colds and experimentally induced rhinovirus infections. Variability in symptom expression remains a hallmark of URI. Although specific pathogens are associated with the severity and distribution of symptoms at the population level, symptoms are poor predictors of etiology at the individual level. Infection itself is an imperfect predictor of symptom expression, as asymptomatic infections occur frequently, and as URI-like symptoms occur in people in whom it is not possible to demonstrate infections.16 Even among people with documented experimental infections of single strains of virus, variance outweighs central tendency in all symptom measurements.17,18

Pages

Recommended Reading

Are progesterone or progestogens effective in managing premenstrual syndrome (PMS) symptoms?
MDedge Family Medicine
Can patients hospitalized with community-acquired pneumonia be treated safely and effectively with oral antibiotics?
MDedge Family Medicine
Does long-term erythromycin treatment reduce the number of common cold infections and subsequent exacerbations in patients with chronic obstructive pulmonary disease (COPD)?
MDedge Family Medicine
Should patients with acute cough or bronchitis be treated with β2-agonists?
MDedge Family Medicine
Does long-term bupropion (Zyban) use prevent smoking relapse after initial success at quitting smoking?
MDedge Family Medicine
Can a simple warfarin initiation scheme predict the maintenance dose in patients with nonrheumatic atrial fibrillation?
MDedge Family Medicine
Which oral triptans are effective for the treatment of acute migraine?
MDedge Family Medicine
Experience, Expertise, or Specialty? Uses and Misuses of a Reference
MDedge Family Medicine
What Do We Know About Socioeconomic Status And Congestive Heart Failure? A Review of the Literature
MDedge Family Medicine
Defining Effective Clinician Roles in End-of-Life Care
MDedge Family Medicine